Yu Du
Tianjin University of Traditional Chinese Medicine(CN)University of Electronic Science and Technology of China(CN)Sun Yat-sen University(CN)Eli Lilly (United States)(US)Bengbu Medical College(CN)First Teaching Hospital of Tianjin University of Traditional Chinese Medicine(CN)Stomatology Hospital(CN)Third Affiliated Hospital of Sun Yat-sen University(CN)
Publications by Year
Research Areas
Acupuncture Treatment Research Studies, Diabetes Treatment and Management, Pharmacology and Obesity Treatment, Metabolism, Diabetes, and Cancer, Dysphagia Assessment and Management
Most-Cited Works
- → Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial(2023)877 cited
- → Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA(2023)337 cited
- → LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept(2022)254 cited
- → Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype(2017)238 cited
- → Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial(2024)205 cited
- → Efficacy of Intensive Acupuncture Versus Sham Acupuncture in Knee Osteoarthritis: A Randomized Controlled Trial(2020)